Eikonizo Therapeutics, Inc.

Biotechnology company · Beverly, Massachusetts, United States

Eikonizo Therapeutics, Inc. is a biotechnology company headquartered in Beverly, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.3 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $371,352 sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Eikonizo Therapeutics at a glance

Typebiotechnology company

HeadquartersBeverly, Massachusetts, United States

Earliest incorporation on record2017

Employees (self-reported, 2025)8

SEC CIK1735756

What does Eikonizo Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $1.3 million in total (2020 to 2025). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute on Aging, National Institute of Neurological Disorders and Stroke.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $371,352 sold (2018).

Frequently asked questions about Eikonizo Therapeutics

Where is Eikonizo Therapeutics headquartered?

Eikonizo Therapeutics, Inc. is headquartered in Beverly, Massachusetts, United States.

What does Eikonizo Therapeutics do?

Eikonizo Therapeutics, Inc. is a biotechnology company.

When was Eikonizo Therapeutics founded?

The earliest incorporation on record for Eikonizo Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Rogers Sciences, Inc.Beverly, Massachusetts, United States
VirTech Bio, Inc.Beverly, Massachusetts, United States
Dermalytica Inc.Beverly, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences